Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zymeworks (ZYME) Return on Sales (2021 - 2025)

Zymeworks' Return on Sales history spans 5 years, with the latest figure at 0.16% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 16.0% to 0.16% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% increase, with the full-year FY2025 number at 0.01%, up 1.0% from a year prior.
  • Return on Sales hit 0.16% in Q4 2025 for Zymeworks, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for ZYME hit a ceiling of 0.01% in Q4 2022 and a floor of 0.38% in Q1 2022.
  • Historically, Return on Sales has averaged 0.07% across 5 years, with a median of 0.04% in 2024.
  • Biggest five-year swings in Return on Sales: surged 37bps in 2023 and later decreased -16bps in 2025.
  • Tracing ZYME's Return on Sales over 5 years: stood at 0.05% in 2021, then surged by 119bps to 0.01% in 2022, then tumbled by -190bps to 0.01% in 2023, then increased by 11bps to 0.01% in 2024, then tumbled by -2063bps to 0.16% in 2025.
  • Business Quant data shows Return on Sales for ZYME at 0.16% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.